In plain words
Under capitation, an insurer pays the hospital a fixed fee per member per month to cover members' care. The question is when to recognise it and how to treat risk-sharing terms. The fee usually pays for standing ready to provide care, so it is recognised evenly over the coverage period. Clawbacks or bonuses tied to utilisation are variable consideration, estimated and constrained each period, reducing or increasing revenue.
Why it matters
Capitation revenue can look deceptively simple (a fixed fee) but embeds both a stand-ready-obligation timing question and variable-consideration risk-sharing features; recognizing it on a fee-for-service pattern instead of ratably, or ignoring clawback risk until settled, misstates revenue timing and hides utilization risk that is central to evaluating a managed-care provider's financial health.
Diagnostic questions
Is the capitation performance obligation best characterized as standing ready to serve the covered population, satisfied ratably over the coverage period, or as delivery of distinct medical services as rendered? Does the contract include risk corridors, shared savings or utilization-based bonuses and penalties that constitute variable consideration requiring the constraint to be applied? When the same covered population also generates fee-for-service billings outside the capitation scope, how is revenue allocated between the two streams without double counting or omission?
Recognition
1) Characterize the performance obligation: is the fixed PMPM fee compensation for standing ready to provide care over the coverage period (most common), or for delivery of distinct identifiable services? 2) For a stand-ready obligation, recognize revenue ratably (typically straight-line by time elapsed) over the coverage period, unless utilization data suggests a more representative output measure of the pattern of benefit. 3) Separate any fee-for-service components billed outside the capitation scope as distinct performance obligations recognized as delivered, do not commingle tracking with capitation revenue. 4) Identify risk-sharing features (risk corridors, shared savings, utilization-based bonuses/penalties, quality metrics) as variable consideration requiring separate estimation. 5) Estimate and constrain the variable consideration each reporting period using the expected value or most likely amount method, updating for actual utilization/quality data as it becomes available. 6) Reassess membership counts monthly since PMPM revenue is directly a function of the covered population.
Measurement
Recognize the fixed PMPM fee over time on a straight-line (time-elapsed) basis consistent with the stand-ready nature of the obligation, unless a more representative output/input measure of the pattern of benefit exists (e.g. utilization intensity data); estimate variable consideration from risk-sharing, utilization corridors or quality bonuses using the expected value or most likely amount method, constraining the estimate to the amount highly probable not to reverse significantly; reassess membership counts and risk-pool settlement estimates each reporting period as actuarial and claims data develops.
Presentation & disclosure
Disclose the nature of the capitation arrangement and the policy for recognizing stand-ready obligations; disclose the amount and nature of variable consideration constrained or subsequently resolved during the period (risk corridors, quality bonuses/penalties); disclose membership volumes underlying capitation revenue; disclose separately any fee-for-service revenue earned from the same population outside the capitation scope.
Common mistakes
- Recognizing capitation revenue only when individual services are rendered instead of ratably over the coverage period, understating revenue in low-utilization months and overstating it in high-utilization months
- ignoring utilization risk-sharing clawback provisions until settled instead of estimating and constraining them each period
- commingling capitation revenue with fee-for-service revenue without separate tracking, obscuring the true nature and risk of each stream
- using a stale membership count instead of the actual current covered population each month.
Simple example
A hospital group receives SAR 45 per member per month from an insurer to cover primary care for 20,000 members, generating SAR 900,000 monthly recognized ratably; a year-end risk corridor could require repaying up to SAR 1,000,000 if utilization exceeds a cap, estimated at SAR 400,000 (constrained expected value) at the current quarter. Each month, as the stand-ready obligation is satisfied: Dr Cash/Receivable - insurer 900,000 / Cr Capitation revenue 900,000. Recognizing the constrained estimate of the utilization clawback as a reduction of revenue: Dr Capitation revenue 400,000 / Cr Refund liability - risk corridor 400,000. If, at year-end reconciliation, the actual clawback is confirmed at SAR 450,000, an additional adjustment is made: Dr Capitation revenue 50,000 / Cr Refund liability - risk corridor 50,000; and on payment: Dr Refund liability - risk corridor 450,000 / Cr Cash 450,000.
Professional judgment
Determining whether capitation is a single stand-ready performance obligation or a series of distinct service obligations, and estimating utilization-based risk-sharing settlements, both require significant judgment informed by actuarial and utilization data; a further grey area is choosing between the expected value and most likely amount methods for the risk corridor, which can produce materially different constrained estimates especially early in the coverage period when utilization data is thin.
Source basis
IFRS 15 · Revenue from Contracts with Customers
Paragraph references
Verified against the official standard texts used in the IFRS Expert skill.
Related issues
- IFRS 15Patient service revenue and insurer billing
- IFRS 15Insurance rejections as variable consideration
- IFRS 15Government healthcare contracts
- IFRS 15Revenue disaggregation across service lines and payors
- IFRS 15Contract liabilities from prepaid packages and deposits
- IFRS 15Principal versus agent in pharmacy and drug dispensing
Educational and navigation content only. Not professional advice. Does not reproduce official IFRS/IAS text. Consult the authoritative standards and qualified professionals; professional judgment may still be required.
